 |
市场调查报告书
商品编码
1550566
Leuprolide Acetate的全球市场：按应用、按产品形式、途径、按分销管道、按地区Leuprolide Acetate Market, By Application, By Product Form, By Route of Administration, By Distribution Channel, By Geography |
||||||
预计2024年全球Leuprolide Acetate市场规模将达38.2亿美元，2024年至2031年复合年增长率为6.2%，2031年将达58.1亿美元。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 38.2亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 预测 2024-2031 年复合年增长率： | 6.20% | 2031 年金额预测 | 58.1亿美元 |
Leuprolide Acetate的全球市场是指Leuprolide Acetate药物的医药市场，醋酸亮丙瑞林是天然存在的促性腺激素分泌释放激素（GnRH）的合成非胜胜肽类似物。Leuprolide Acetate用于治疗摄护腺癌、乳癌、子宫内膜异位症和子宫肌瘤。作为促性腺激素分泌释放激素（GnRH）受体的促效剂，Leuprolide Acetate透过减少脑下垂体中FSH和LH的分泌来发挥作用，有助于治疗上述疾病。在预测期内，使用Leuprolide Acetate作为治疗剂的癌症和其他疾病的发生率不断增加，可能会推动全球Leuprolide Acetate市场的成长。
市场动态：
全球摄护腺癌、乳癌、子宫内膜异位症和子宫肌瘤盛行率的上升可能会推动全球Leuprolide Acetate市场的成长。根据世界癌症研究基金会的数据，摄护腺癌是全世界男性第二常见的癌症。新兴市场有利的药物核准情况和不断增加的医疗保健支出将推动市场成长。然而，与Leuprolide Acetate製剂相关的高成本以及一些国家对替代治疗方法的偏好可能会阻碍市场成长。Leuprolide Acetate创新药物输送系统的持续研发活动可以在不久的将来为市场参与者提供潜在的机会。
本研究的主要特点
本报告对全球Leuprolide Acetate市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%） 。
它还说明了各个细分市场的潜在商机，并为该市场提供了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球Leuprolide Acetate市场的主要企业概况。
本研究涵盖的主要企业包括武田製药、丽珠製药、北京博奥特、赛诺菲、太阳製药、艾伯维、辉瑞等。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
Leuprolide Acetate全球市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过在分析全球Leuprolide Acetate市场时所使用的各种策略矩阵来促进他们的决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章市场动态、法规及趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- PEST分析
- 波特的分析
- 併购场景
第四章全球Leuprolide Acetate市场，依应用分类，2019-2031（十亿美元）
- 摄护腺癌
- 子宫内膜异位症
- 子宫肌瘤
- 中枢性早熟症
- 不孕症
- 荷尔蒙疗法
- 其他的
第五章全球Leuprolide Acetate市场，依产品形式，2019-2031（十亿美元）
- 预填充式注射器
- 管瓶
- 冻干粉
第六章 全球Leuprolide Acetate市场，依给药途径，2019-2031 年（十亿美元）
- 肌肉注射
- 皮下的
- 经皮的
- 移植
第 7 章 全球Leuprolide Acetate市场，依通路划分，2019-2031 年（十亿美元）
- 医院药房
- 零售药房
- 网路药房
第8章全球Leuprolide Acetate市场，按地区，2019-2031（十亿美元）
- 拉丁美洲
- 欧洲
- 亚太地区
第9章 中东
- 按应用分類的市场规模和预测（十亿美元）
- 按产品类型分類的市场规模和预测（十亿美元）
- 按管理途径分類的市场规模和预测（十亿美元）
- 按分销管道分類的市场规模和预测（十亿美元）
- 按国家/地区分類的市场规模和预测（十亿美元）
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 按应用分類的市场规模和预测（十亿美元）
- 按产品类型分類的市场规模和预测（十亿美元）
- 按管理途径分類的市场规模和预测（十亿美元）
- 按分销管道分類的市场规模和预测（十亿美元）
- 按国家/地区分類的市场规模和预测（十亿美元）
- 南非
- 北非
- 中部非洲
第10章竞争格局
- Sun Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan NV
- Ferring Pharmaceuticals
- GSK（GlaxoSmithKline）
- Bayer AG
- Pfizer Inc.
- Hikma Pharmaceuticals PLC
- Aurobindo Pharma
- Amgen Inc.
- EMD Serono, Inc.
- Novartis AG
- Sandoz International GmbH
- Apotex Inc.
- Fresenius Kabi AG
- Bausch Health Companies Inc.
- Hetero Labs Limited
- ZydusCadila
- Cipla Limited
第十一章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第十二章参考文献与调查方法
- 参考
- 调查方法
- 出版商
Global leuprolide acetate market is estimated to be valued at USD 3.82 Billion in 2024 and is expected to reach USD 5.81 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 3.82 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 6.20% | 2031 Value Projection: | US$ 5.81 Bn |
Global leuprolide acetate market refers to the pharmaceutical market for leuprolide acetate drugs, which is a synthetic nonapeptide analog of naturally occurring gonadotropin-releasing hormone (GnRH). Leuprolide acetate is used as a medication to treat prostate cancer, breast cancer, endometriosis and uterine fibroids. As an agonist of gonadotropin-releasing hormone (GnRH) receptor, leuprolide acetate works by reducing the secretion of FSH and LH from the pituitary gland which helps in treatment of above-mentioned conditions. Increasing incidence of cancers and other disorders for which leuprolide acetate is used as a therapeutic drug can drive the global leuprolide acetate market growth during the forecast period.
Market Dynamics:
Rising prevalence of prostate cancer, breast cancer, endometriosis and uterine fibroids across the globe can drive the global leuprolide acetate market growth. According to World Cancer Research Fund, prostate cancer is the second most commonly diagnosed cancer in men globally. Favorable drug approval scenario and increasing healthcare expenditure in developing nations can drive the market growth. However, high costs associated with leuprolide acetate drugs and preference of alternative treatment options in some countries can hamper the market growth. Ongoing research & development activities for development of innovative drug delivery systems of leuprolide acetate can provide potential opportunities for market players in the near future.
Key features of the study:
This report provides in-depth analysis of the global leuprolide acetate market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global leuprolide acetate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Takeda Pharmaceuticals, Livzon Pharmaceutical, Beijing Biote, Sanofi, Sun Pharmaceutical, AbbVie, and Pfizer.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global leuprolide acetate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leuprolide acetate market
Detailed Segmentation-
- By Application
- Prostate Cancer
- Endometriosis
- Uterine Fibroids
- Central Precocious Puberty
- Infertility
- Hormone Therapy
- Others
- By Product Form
- Pre-filled Syringes
- Vials
- Lyophilized Powder
- By Route of Administration
- Intramuscular
- Subcutaneous
- Intranasal
- Implantation
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Key Players Insights
- Sun Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Ferring Pharmaceuticals
- GSK (GlaxoSmithKline)
- Bayer AG
- Pfizer Inc.
- Hikma Pharmaceuticals PLC
- Aurobindo Pharma
- Amgen Inc.
- EMD Serono, Inc.
- Novartis AG
- Sandoz International GmbH
- Apotex Inc.
- Fresenius Kabi AG
- Bausch Health Companies Inc.
- Hetero Labs Limited
- Zydus Cadila
- Cipla Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Leuprolide Acetate Market, By Application
- Global Leuprolide Acetate Market, By Product Form
- Global Leuprolide Acetate Market, By Route of Administration
- Global Leuprolide Acetate Market, By Distribution Channel
- Global Leuprolide Acetate Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Leuprolide Acetate Market, By Application, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Endometriosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Uterine Fibroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Central Precocious Puberty
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Infertility
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hormone Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Leuprolide Acetate Market, By Product Form, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Pre-filled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Lyophilized Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Leuprolide Acetate Market, By Route of Administration, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Implantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Leuprolide Acetate Market, By Distribution Channel, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Leuprolide Acetate Market, By Region, 2019 - 2031, USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
9. Middle East
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Product Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Sub-region, 2019 - 2031, (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ferring Pharmaceuticals
- GSK (GlaxoSmithKline)
- Bayer AG
- Pfizer Inc.
- Hikma Pharmaceuticals PLC
- Aurobindo Pharma
- Amgen Inc.
- EMD Serono, Inc.
- Novartis AG
- Sandoz International GmbH
- Apotex Inc.
- Fresenius Kabi AG
- Bausch Health Companies Inc.
- Hetero Labs Limited
- ZydusCadila
- Cipla Limited
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
